Updated results from CARTITUDE-1: Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T (CAR-T) cell therapy, in relapsed/refractory multiple myeloma (RRMM)

被引:0
作者
Jagannath, Sundar [1 ]
Berdeja, Jesus G. [2 ]
Jakubowiak, Andrzej [3 ]
Agha, Mounzer [4 ]
Cohen, Adam [5 ]
Madduri, Deepu [1 ]
Hari, Parameswaran [6 ]
Yeh, Tzu-Min [7 ]
Olyslager, Yunsi [8 ]
Banerjee, Arnob [9 ]
Jackson, Carolyn C. [7 ]
Allred, Alicia [9 ]
Zudaire, Enrique [9 ]
Deraedt, William [8 ]
Wu, Xiaoling [10 ]
Pacaud, Lida [10 ]
Akram, Muhammad [10 ]
Lin, Yi [11 ]
Martin, Thomas [12 ]
Usmani, Saad Z. [13 ]
机构
[1] Mt Sinai Hosp, New York, NY 10029 USA
[2] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[3] Univ Chicago, Chicago, IL 60637 USA
[4] UPMC, Hillman Canc Ctr, Pittsburgh, PA USA
[5] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[6] Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA
[7] Janssen R&D, Raritan, NJ USA
[8] Janssen R&D, Beerse, Belgium
[9] Janssen R&D, Spring House, PA USA
[10] Legend Biotech USA Inc, Piscataway, NJ USA
[11] Mayo Clin, Rochester, MI USA
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OAB-024
引用
收藏
页码:S15 / S16
页数:2
相关论文
empty
未找到相关数据